Presentation Information
[MO14-1]Effectiveness of Semaglutide on All-cause Death and Cardiovascular Outcomes in Type 2 Diabetes and Chronic Kidney Disease
Takefumi Kishimori1
Takao Kato2, Atsuyuki Wada1, Akira Tani1, Yamaji Ryosuke1, Jumpei Koike1, Yoshihiro Iwasaki1, Takafumi Yagi1, Masaharu Okada1 (1.Department of Cardiovascular Medicine, Omi Medical Center, Japan, 2.Kyoto University Graduate School of Medicine)
Takao Kato2, Atsuyuki Wada1, Akira Tani1, Yamaji Ryosuke1, Jumpei Koike1, Yoshihiro Iwasaki1, Takafumi Yagi1, Masaharu Okada1 (1.Department of Cardiovascular Medicine, Omi Medical Center, Japan, 2.Kyoto University Graduate School of Medicine)
Password required to view
Password is listed in "Guidelines for Attendees" section (p.34) on the CVIT2025 Pocket Program.